While we at Byrdie are huge fans of well-placed blush, we sympathize with the plight of involuntary inflammation and redness of the skin. And that's why we're pretty excited to share some great news for the 16 million Americans and counting who suffer from rosacea: There's a breakthrough new treatment option that promises to eradicate symptoms in less than a month.
Allergan, a global pharmaceutical company, recently announced the FDA approval of Rhofade cream, a topical treatment for persistent facial erythema (redness) associated with rosacea. Approval of this rosacea treatment comes after two clinical trials in which a once-daily application of Rhofade was proven to reduce redness for 12 hours. It's a major breakthrough, considering there aren’t many options to treat rosacea other than soothing lotions like Avene Redness Relief Soothing Cream ($36) and managing triggers like sun exposure, stress, and diet.
Of the new rosacea treatment, Dr. Robert Weiss, clinical trial investigator and director of Maryland Laser, Skin & Vein Institute, told Allergan, “Doctors will now be able to provide their patients with an effective once-daily treatment option to help manage this condition.”
While there is not yet a cure for rosacea, Rhofade, which will be available for sale in May of 2017, is a step in the right direction.
Want tips on how to deal with rosacea? Check out the rosacea diet: what to eat (and avoid) for calm, happy skin.